Join experts from the UK’s Office of Health Economics as they provide insights into innovative approaches to reimbursement for cell and gene therapies.
New York Tech’s 2023 Biotechnology Conference: Regenerative Medicine: Improving the Way We Live, Play and Feel, will gather recognized leaders, top global researchers, and medical professionals, plus innovators in the healthcare and biotechnology sectors.
The Advanced Therapies Congress is Europe’s largest cell and gene therapy conference and exhibition. Taking place 14th-15 March 2023 at the ExCel in London, welcoming 2,000 attendees, 100 exhibitors, 200 innovative young start-ups and 300 speakers from across the entire value chain of cell and gene therapy development; including forward thinking pharma companies, researchers, clinicians, academics, HTAs, payers and regulators.
Europe’s cell and gene therapy congress for groundbreaking manufacturing, commercialization, and supply chain strategies. Hear from the world-renowned leaders share the latest analytical techniques & vector technologies to revolutionize your cell, gene & gene edited ex vivo cell therapy programs. Register today to secure your place.
The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.
Now in its 13th annual edition, the World Orphan Drug Congress Europe, together with the co-located Cell & Gene Therapy Congress, will continue to bring experts from the whole value chain under one roof, where you get to meet decision makers in the areas that are most applicable for your business offering.
Register for the event here: www.terrapinn.com/WODC/ARM
California Life Sciences is preparing for our December issue of our digital magazine, Life Sciences Insights. For this edition, we’ll be exploring the topic of Cell and Gene Therapy: the current market scenario, the latest trends and drivers, and the overall market environment. We invite your organization to contribute an article.
This topical conference focuses on emerging organoid cell culture, tissue engineering, and stem cell technologies that have revolutionized the study of human GI tissues. The 2022 James W. Freston Single Topic conference will bring together a diverse group of experts, including developmental biologists, physiologists, pathologists, bioengineers, tissue-chip developers, and clinicians, to present state-of-the-art research and to stimulate new interdisciplinary collaborations.
